Nektar Therapeutics
NKTR· Nasdaq
Released Aug 4, 2016, during market hours
10-Q filed Aug 4, 2016, 35 days after period end · 0001564590-16-022647
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2016 | Q2 2015 | Q2 2014 | Q2 2013 |
|---|---|---|---|---|
| Revenue | $32.77M | $22.66M | $28.51M | $33.86M |
| Net Income | -$48.60M | -$52.66M | -$32.64M | -$42.75M |
| EPS Diluted | -$0.36 |
Nektar Therapeutics · CIK 906709 · Engraved from SEC EDGAR
| -$0.40 |
| -$0.26 |
| -$0.37 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.